Scleroderma and survival.
作者信息
Silman A J
机构信息
Arthritis and Rheumatism Council Epidemiology Research Unit, Manchester University Medical School, UK.
出版信息
Ann Rheum Dis. 1991 Apr;50(4):267-9. doi: 10.1136/ard.50.4.267.
Abstract
摘要
相似文献
1
Scleroderma and survival.硬皮病与生存率
Ann Rheum Dis. 1991 Apr;50(4):267-9. doi: 10.1136/ard.50.4.267.
2
[Survival and prognostic significance of a kidney lesion in systemic scleroderma].
Ter Arkh. 1982;54(7):99-102.
3
Mortality in the Waikato Hospital Systemic Sclerosis Cohort.怀卡托医院系统性硬化症队列中的死亡率。
Int J Rheum Dis. 2018 Jan;21(1):253-260. doi: 10.1111/1756-185X.13111. Epub 2017 Jun 4.
4
Severe organ involvement in systemic sclerosis with diffuse scleroderma.系统性硬化症伴弥漫性硬皮病的严重器官受累。
Arthritis Rheum. 2000 Nov;43(11):2437-44. doi: 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U.
5
Review of UK data on the rheumatic diseases--9. Scleroderma.英国风湿性疾病数据综述——9. 硬皮病。
Br J Rheumatol. 1991 Oct;30(5):365-7. doi: 10.1093/rheumatology/30.5.365.
6
[Causes of death of patients with systemic sclerosis].[系统性硬化症患者的死因]
Pol Merkur Lekarski. 2006 Oct;21(124):341-4.
7
Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.
Ann Intern Med. 1971 Sep;75(3):369-76. doi: 10.7326/0003-4819-75-3-369.
8
Renal scleroderma and pregnancy.
Obstet Gynecol. 1974 Sep;44(3):349-54.
9
Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.系统性硬皮病患者肾危象：瑞典队列研究的生存率、肾脏预后及 RNA 聚合酶 III 抗体的风险因素
Scand J Rheumatol. 2012 Feb;41(1):39-43. doi: 10.3109/03009742.2011.610032. Epub 2011 Nov 1.
10
Scleroderma--demographics and survival.硬皮病——人口统计学与生存率
J Rheumatol Suppl. 1997 May;48:58-61.
引用本文的文献
1
Microstomia is associated with functional impairment and is a poor prognostic factor in systemic sclerosis - a single center observational study with survival analysis.小口畸形与功能障碍相关，并且是系统性硬化症的预后不良因素——一项带有生存分析的单中心观察性研究。
BMC Oral Health. 2024 Nov 15;24(1):1390. doi: 10.1186/s12903-024-05178-6.
2
Systemic sclerosis: To subset or not to subset, that is the question.系统性硬化症：是否进行亚组分析，这是个问题。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S222-S227. doi: 10.5152/eurjrheum.2020.19116. Epub 2020 Jul 6.
3
Whole-genome bisulfite sequencing in systemic sclerosis provides novel targets to understand disease pathogenesis.全基因组亚硫酸氢盐测序为系统性硬化症提供了新的靶点，有助于理解疾病发病机制。
BMC Med Genomics. 2019 Oct 24;12(1):144. doi: 10.1186/s12920-019-0602-8.
4
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.早期弥漫性皮肤系统性硬化症两年死亡率预测规则的推导和验证。
Arthritis Rheumatol. 2014 Jun;66(6):1616-24. doi: 10.1002/art.38381.
5
Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis.可触及肌腱摩擦音在早期弥漫性皮肤系统性硬化症中的意义。
Arthritis Care Res (Hoboken). 2013 Aug;65(8):1385-9. doi: 10.1002/acr.21964.
6
Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study.系统性硬化症患者的死亡风险因素及3年生存率：法国ItinérAIR-Sclérodermie研究
Rheumatology (Oxford). 2009 Mar;48(3):304-8. doi: 10.1093/rheumatology/ken488. Epub 2009 Jan 27.
7
Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.西班牙系统性硬化症患者的生存预后因素及发病标志物
Ann Rheum Dis. 1997 Dec;56(12):723-8. doi: 10.1136/ard.56.12.723.
本文引用的文献
1
The natural history of progressive systemic sclerosis (diffuse scleroderma).进行性系统性硬化症（弥漫性硬皮病）的自然病史。
Bull Rheum Dis. 1963 Feb;13:301-4.
2
Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases.雷诺现象及系统性硬化症其他临床特征的预后意义。一项对271例病例的研究。
Circulation. 1960 Jun;21:1088-95. doi: 10.1161/01.cir.21.6.1088.
3
Systemic scleroderma, A clinical study of 727 cases.系统性硬化症：727例临床研究
Arch Dermatol. 1961 Sep;84:359-71. doi: 10.1001/archderm.1961.01580150005001.
4
Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features.奥克兰地区的进行性系统性硬化症：一项着重于预后特征的十年回顾
Aust N Z J Med. 1981 Dec;11(6):657-62. doi: 10.1111/j.1445-5994.1981.tb03542.x.
5
Malignancy in progressive systemic sclerosis--association with breast carcinoma.
J Rheumatol. 1983 Aug;10(4):665-6.
6
Scleroderma in the elderly, with special reference to the CRST syndrome.老年人硬皮病，特别提及CRST综合征。
J Am Geriatr Soc. 1971 Mar;19(3):224-8. doi: 10.1111/j.1532-5415.1971.tb02625.x.
7
Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients.
J Chronic Dis. 1973 Oct;26(10):647-60. doi: 10.1016/0021-9681(73)90054-4.
8
Incidence of lung cancer in systemic sclerosis.
J Rheumatol. 1985 Dec;12(6):1136-9.
9
Cancer and systemic sclerosis. An epidemiologic study.
Arthritis Rheum. 1985 Dec;28(12):1336-40. doi: 10.1002/art.1780281204.
10
Zotero 插件